Abstract
Purpose
Recurrent miscarriage (RM) affects up to 2–3% of couples of reproductive age. There are several causes for this condition, including immunologic. The embryo is considered an allograft, subject to the rejection mechanisms of the maternal immune system. Immunotherapy involving immunization with lymphocytes is considered in cases of idiopathic RM. However, there is still no consensus regarding the efficacy and safety of this therapy.
Methods
This systematic review and meta-analysis evaluated the data available in the literature regarding the efficacy and safety of the use of immunotherapy with lymphocytes in couples with history of RM. Searches in PubMed/Medline, SCOPUS, and Cochrane Library databases were conducted, using the following keywords: “recurrent miscarriage,” “lymphocyte immunotherapy,” and “meta-analysis.” Statistical analyses were performed using Review Manager 5.3 (RevMan), version 5.3.
Results
Six published meta-analysis were retrieved; two found no improvements in the rate of live births after the use of immunization with lymphocytes in the treatment of RM, and four found a beneficial effect of the use of immunotherapy with lymphocytes in cases of RM, with significant improvements in the rate of live births.
Conclusion
Data available in the literature supports the efficacy and safety of immunotherapy with lymphocytes in cases of RM without an identified cause.
Similar content being viewed by others
References
Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601–611
Practice Committee of American Society for Reproductive Medicine (2013) Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 99:63
Garrido-Gimenez C, Alijotas-Reig J (2015) Recurrent miscarriage: causes, evaluation and management. Postgrad Med J 91:151–162
Medawar PD (1953) Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symposium of the Society for Experimental Biology, p 320
Clarke B, Kirby DR (1966) Maintenance of histocompatibility polymorphisms. Nature 211:999–1000
Beer AE, Quebbeman JF, Ayers JW, Haines RF (1981) Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 141:987–999
Kwak JY, Gilman-Sachs A, Moretti M, Beaman KD, Beer AE (1998) Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am J Reprod Immunol 40:352–358
Yokoo T, Takakuwa K, Ooki I, Kikuchi A, Tamura M, Tanaka K (2006) Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband’s mononuclear cells. Fertil Steril 85:1452–1458
Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T et al (2005) Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+ CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166:811–822
Kwak-Kim J, Han AR, Gilman-Sachs A, Fishel S, Leong M, Shoham Z (2013) Current trends of reproductive immunology practices inin vitro fertilization (IVF)—a first world survey using IVF-worldwide.com. Am J Reprod Immunol 69:12–20
Taylor C, Faulk WP (1981) Prevention of recurrent spontaneous abortions with leukocyte transfusion. Lancet 2:68–70
Mowbray JF, Gibbons C, Lidell H, Reginald PW, Underwood JL, Beard RW (1985) Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1:941–943
Khonina NA, Broitman EV, Shevela EY, Pasman NM, Chernykh ER (2013) Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch Gynecol Obstet 288:933–937
Kheshtchin N, Gharagozloo M, Andalib A, Ghahiri A, Maracy MR, Rezaei A (2010) The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy. Am J Reprod Immunol 64:104–112
Szpakowski A, Malinowski A, Zeman K, Wilczyński J, Kolasa D, Nowak M et al (2001) The influence of paternal lymphocytes immunization on percentage of peripheral blood CD16+/CD56+ cells in women with primary recurrent spontaneous abortion. Ginekol Pol 72:1063–1068
Wu L, Luo LH, Zhang YX, Li Q, Xu B, Zhou GX et al (2014) Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy. Reprod Biol Endocrinol 12:74
Pandey MK, Agrawal S (2004) Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lynphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 4:289–298
Toshiyuki T (2004) Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: is paternal lymphocyte immunization a relic of the past. J Nippon Med Sch 71:308–313
Kwak JY, Kwak FM, Gilman-Sachs A, Beaman KD, Cho DD, Beer AE (2000) Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells. Early Pregnancy 4:154–164
Wong LF, Porter TF, Scott JR (2014) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev (10):CD000112
Opelz G, Sengar DP, Mickey MR, Terasaki PI (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5:253–259
Clark DA (2012) The end of evidence-based medicine? Inflammopharmacol 20:187–193
Fraser EJ, Grimes DA, Schultz KF (1993) Immunization as therapy for recurrent spontaneous abortion: a review and metaanalysis. Obstet Gynecol 82:854–859
Collins J, Roberts R (1994) Immunotherapy for recurrent spontaneous abortion: analysis 1. Am J Reprod Immunol 32:275–280
Coulam CB, Clark DA, Collins J, Scott JR (1994) Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 32:55–72
Pandey MK, Thakur S, Agrawal S (2004) Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch Gynecol Obstet 269:161–172
Liu Z, Xu H, Kang X, Wang T, He L, Zhao A (2016) Allogenic lymphocyte immunotherapy for unexplained recurrent spontaneous abortion: a meta-analysis. Am J Reprod Immunol 76:443–453
Cauchi MN, Lim D, Young DE (1991) Treatment of recurrent aborters by immunization with paternal cells-controlled trial. Am J Reprod Immunol 25:16–17
Ho HN, Thomas HJ, Honjou H (1991) Immunotherapy for recurrent spontaneous abortions in a Chinese population. Am J Reprod Immunol 25:10–15
Clark DA, Daya S (1991) Trials and tribulation in the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 25:18–24
Gatenby PA, Cameron K (1993) Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 29:88–94
Paul A, Gatenby PA, Helen M (1989) Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: correlates with outcome. Am J Reprod Immunol 19:21–27
Daya S, Joanne G (1994) The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 32:294–302
Illeni MT, Marelli G, Parazzin F (1994) Immunotherapy and recurrent abortion: a randomized clinical trial. Hum Reprod 9:1247–1249
Christiansen OB, Mathiesen O, Meretehu S (1994) Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstet Ginecol Scand 73:261–268
Carp HJ, Toder V, Torchinsky A (1997) Allogenic leukocyte immunization after five or more miscarriages. Hum Reprod 12:250–255
Pandey MK, Halder A, Agarwal S (2003) Immunotherapy in recurrent spontaneous abortion: randomized and non-randomized trials. Internet J Gynecol Obstet 2:13
Hong L, Huaixiu W, Jing W (2003) The lymphocyte injects and treats the habitual abortion that the immune factor causes. Med Mag Shanxi 32:308–309
Yanping C, Xiaoye Z, Qingmei B (2011) Study of immunotherapy with lymphocytes in women with recurrent spontaneous abortion. Mod Prev Med 38:1626–1627
Lin S, Yan S, Shan E (2012) Analysis the efficacy of immunotherapy with lymphocytes for recurrent spontaneous abortion. Jilin Med 33:1822–1823
Aiwu W, Mingzhu L, Runzhi W (2013) Preventive treatment of unexplained recurrent spontaneous abortion and effect on pregnancy outcomes by lymphocytes immunotherapy. China J Chin Med 28:876–878
Bin T, Kaishu H, Wenquan Z (2013) Analysis of lymphocytes immunotherapy for recurrent spontaneous abortion. Chin Med Treat Works 21:171–172
Ober C, Karrison T, Odem RB, Barnes RB, Branch DW, Stephenson MD (1999) Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 354:365–369
Clark DA (2009) Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am J Reprod Immunol 61:75–84
Yu HL, Deng XH, Chao L, Chen C, Han YL (2013) Study on positive rate of blocking antibody in women with recurrent spontaneous abortion administered by route and frequency of paternal lymphocyte immunotherapy. Zhonghua Fu Chan Ke Za Zhi 48:903–906
Khonina NA, Broitman EV, Shevela EY, Pasman NM, Chernykh ER (2013) Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch Gynecol Obstet 288:933–937
Liang P, Mo M, Li GG, Yin B, Cai J, Wu T et al (2012) Comprehensive analysis of peripheral blood lymphocytes in 76 women with recurrent miscarriage before and after lymphocyte immunotherapy. Am J Reprod Immunol 68:164–174
Gharesi-Fard B, Zolghadri J, Haghbin H (2013) Soluble CD30 (sCD30) and effectiveness of leukocyte therapy in recurrent pregnancy loss patients. J Reprod Immunol 97:240–244
Kling C, Steinmann J, Westphal E, Magez J, Kabelitz D (2006) Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum Reprod 21:429–435
Kling C, Schmutzler A, Wilke G, Hedderich J, Kabelitz D (2008) Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions. Arch Gynecol Obstet 278:135–142
Lymphocyte Immune Theraphy (LIT) Letter. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm105848.htm. Accessed 22 Jan 2015
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was not funding.
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Cavalcante, M.B., Sarno, M., Araujo Júnior, E. et al. Lymphocyte immunotherapy in the treatment of recurrent miscarriage: systematic review and meta-analysis. Arch Gynecol Obstet 295, 511–518 (2017). https://doi.org/10.1007/s00404-016-4270-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4270-z